We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 853 results
  1. Pregnancy, folic acid, and antiseizure medication

    Background

    Although some antiseizure medications (ASMs) are teratogenic, most people with epilepsy need treatment in pregnancy. The risk of ASM...

    Marte-Helene Bjørk, Håkon Vegrim, ... Elisabeth Synnøve Nilsen Husebye in Clinical Epileptology
    Article Open access 03 July 2023
  2. Antiseizure Medication Interactions A Clinical Guide

    This significantly revised fourth edition provides a practically orientated guide to interactions associated with antiseizure medications. It...

    Philip N. Patsalos
    Book 2022
  3. Long-term antiseizure medication use in patients after meningioma resection: identifying predictors for successful weaning and failures

    Objective

    To define risk factors for meningioma-related seizures and predictors of successful weaning of antiseizure medications following meningioma...

    Erin M. Ellis, Michael R. Drumm, ... Jessica W. Templer in Journal of Neuro-Oncology
    Article 24 October 2023
  4. Synergistic effects of vagus nerve stimulation and antiseizure medication

    Introduction

    Vagus nerve stimulation (VNS) is an effective, non-pharmacological therapy for epileptic seizures. Until now, favorable combinations of...

    Yaroslav Winter, Katharina Sandner, ... Sergiu Groppa in Journal of Neurology
    Article Open access 27 June 2023
  5. Antiseizure Medication Withdrawal in Seizure-Free Patients: What is New for the Pediatrician?

    The American Academy of Neurology (AAN) has recently updated its practise advisory on antiseizure medication withdrawal. The recommendations have...

    Arpita Gupta, Kunal Kumar in Indian Pediatrics
    Article 27 August 2022
  6. Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study

    Background

    Withdrawal of antiseizure medication treatment (ASM) can be considered after completion of antitumour treatment in glioma patients who no...

    Pim B. van der Meer, Linda Dirven, ... Johan A.F. Koekkoek in Journal of Neuro-Oncology
    Article Open access 27 September 2023
  7. Video-EEG monitoring as a valuable tool for antiseizure medication withdrawal in patients with epilepsy: implications for clinical practice and public health policies

    This letter to the editor discusses “the use of video-EEG monitoring to guide antiseizure medication (ASM) withdrawal in patients with epilepsy” [ 1 ]....

    Obed Okwoli Apochi in Neurological Research and Practice
    Article Open access 28 September 2023
  8. Brain tumor related epilepsy: pathophysiological approaches and rational management of antiseizure medication

    Background

    Brain tumor related epilepsy (BTRE) is a common complication of cerebral tumors and its incidence is highly dependent on the type of tumor,...

    Sabine Seidel, Tim Wehner, ... Wenke Grönheit in Neurological Research and Practice
    Article Open access 05 September 2022
  9. Third-Generation Antiseizure Medication in the Treatment of Benzodiazepine-Refractory Status Epilepticus in Poststroke Epilepsy: A Retrospective Observational Register-Based Study

    Background and Objective

    Status epilepticus in poststroke epilepsy is a challenging condition because of multiple vascular comorbidities and the...

    Yaroslav Winter, Katharina Sandner, ... Sergiu Groppa in CNS Drugs
    Article Open access 02 October 2023
  10. Video-EEG-monitoring to guide antiseizure medication withdrawal

    Background

    Discontinuing anti-seizure medication (ASM) should be considered in persons with epilepsy with long-term seizure freedom. Clinicians should...

    Laurien K. L. Dhaenens-Meyer, Elisabeth Schriewer, ... Stefan Wolking in Neurological Research and Practice
    Article Open access 18 May 2023
  11. Incidence of and predictors for antiseizure medication gaps in Medicare beneficiaries with epilepsy: a retrospective cohort study

    Background

    For the two-thirds of patients with epilepsy who achieve seizure remission on antiseizure medications (ASMs), patients and clinicians must...

    Samuel W. Terman, Joshua D. Niznik, ... James F. Burke in BMC Neurology
    Article Open access 01 September 2022
  12. Impact of seizures and antiseizure medication on survival in patients with glioma

    Purpose

    Seizures are a common presenting symptom among patients with low- and high-grade glioma. However, the impact and inter-relationship between...

    Thinisha Sathis Kumar, Wan Muhammad Afnan, ... Vairavan Narayanan in Journal of Neuro-Oncology
    Article 29 August 2022
  13. Neurobehavioral Outcomes of Children with Antenatal Exposure to Antiseizure Medications

    Objectives

    To evaluate the effect of antiepileptic medications prescribed to mothers during pregnancy on the development and behavior of children.

    ...
    Deepa Bhaskaran, Sanjeev Thomas, Liss Maria Scaria in Indian Journal of Pediatrics
    Article 08 June 2024
  14. Antiseizure Drugs and Movement Disorders

    The relationship between antiseizure drugs and movement disorders is complex and not adequately reviewed so far. Antiseizure drugs as a treatment for...

    Michel Sáenz-Farret, Marina A. J. Tijssen, ... Alfonso Fasano in CNS Drugs
    Article 21 July 2022
  15. Interactions Between Direct Oral Anticoagulants (DOACs) and Antiseizure Medications: Potential Implications on DOAC Treatment

    The use of direct oral anticoagulants (DOACs) is increasing because of their superior efficacy and safety compared with vitamin K antagonists....

    Rachel Goldstein, Aviya R. Jacobs, ... Mordechai Muszkat in CNS Drugs
    Article 03 March 2023
  16. The Effect of Antiseizure Medication Administration on Mortality and Early Posttraumatic Seizures in Critically Ill Older Adults with Traumatic Brain Injury

    Background

    Traumatic brain injury (TBI) is a major cause of morbidity and mortality in the United States. Older adults represent an understudied and...

    Adam C. Glaser, John H. Kanter, ... Myles D. Boone in Neurocritical Care
    Article 01 June 2022
  17. Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis

    Background and Objective

    Drug–drug interactions between direct oral anticoagulants (DOAC) and antiseizure medications via the cytochrome P450 (CYP) or...

    Bonaventure Y. Ip, Ho Ko, ... Thomas W. Leung in CNS Drugs
    Article Open access 24 November 2022
  18. Perampanel as first add-on antiseizure medication: Italian consensus clinical practice statements

    Background

    When use of a single antiseizure medication (ASM) fails to induce seizure remission, add-on therapy is justified. Perampanel (PER) is...

    Paolo Bonanni, Antonio Gambardella, ... Giangennaro Coppola in BMC Neurology
    Article Open access 26 October 2021
  19. Efficacy and Tolerability of Intranasal Midazolam Administration for Antiseizure Treatment in Adults: A Systematic Review

    Objective

    The objective of this study was to assess the efficacy and tolerability of intranasal midazolam (in-MDZ) administration for antiseizure...

    Tolga D. Dittrich, Dominik Vock, ... Raoul Sutter in Neurocritical Care
    Article Open access 05 April 2024
  20. Antiseizure Medication Treatment and Outcomes in Patients with Subarachnoid Hemorrhage Undergoing Continuous EEG Monitoring

    Background

    Patients with aneurysmal subarachnoid hemorrhage (aSAH) with electroencephalographic epileptiform activity (seizures, periodic and rhythmic...

    Sahar F. Zafar, Eric S. Rosenthal, ... M. Brandon Westover in Neurocritical Care
    Article 29 November 2021
Did you find what you were looking for? Share feedback.